October 08, 2024

BRASH Syndrome: A Critical Cardiorenal Disorder?

A 66-year-old woman with atrial fibrillation, diabetes, and hypertension developed BRASH syndrome following dehydration, highlighting the critical interplay between heart and kidney function.

Conexiant

October 07, 2024

Euretina 2024: Faricimab Shows Greater Hard Exudate Reduction Compared with Aflibercept

Faricimab’s dual inhibition mechanism led to a greater reduction in HE compared to aflibercept in DME patients.

Conexiant

October 07, 2024

Euretina 2024: Aflibercept Showed Efficacy and Safety vs Laser Therapy in Retinopathy of Prematurity

3-Year Outcomes from FIREFLEYE next study were presented at Euretina 2024.

Conexiant

October 07, 2024

Euretina 2024: 3-Month Outcomes from VOYAGER

The presented abstract discussed global, real-world clinical and anatomical outcomes with faricimab for the treatment of nAMD and DME.

Conexiant

September 27, 2024

ADA opposes new dental therapy model legislation

ALEC adopted model legislation to authorize dental therapy, which the ADA said fails to adequately advance access to quality dental care. 

ADA News

September 23, 2024

ACA May Increase Access to Colorectal Cancer Care Among Underserved Groups

A new study explored whether the Affordable Care Act (ACA) increased guideline-concordant care for colorectal cancer among non-White patients, those from rural areas, and those from the most deprived ...

The ASCO Post

September 19, 2024

Virtual Reality Treatment for Amblyopia Shows Clinically Meaningful Vision Improvement

The real-world data, presented at ARVO 2024

Conexiant

September 19, 2024

Steroid Use Doubled Diabetes Risk in UK Study

UK study of 451,606 hospitalized patients reveals systemic glucocorticoid use associated with 2.6-fold increased risk of new-onset diabetes, with incidence rates of 51.9 vs 18.5 per 100 person-years in exposed vs unexposed groups.

Conexiant

September 19, 2024

Breastfeeding Safe After Breast Cancer: Studies

New data from two international studies reveal breastfeeding after breast cancer, even for women with BRCA mutations, does not increase the risk of recurrence.

Conexiant